Hyper-IgE syndrome with a novel mutation of the STAT3 gene

Clin Exp Dermatol. 2016 Aug;41(6):687-9. doi: 10.1111/ced.12865. Epub 2016 Jun 23.

Authors

S Minakawa¹, H Tanaka², T Kaneko³, Y Matsuzaki³, M Kono⁴, M Akiyama⁴, Y Minegishi⁵, D Sawamura³

Affiliations

¹ Department of Dermatology, Hirosaki University Graduate School of Medicine, Aomori, Japan. [email protected].
² Department of Pediatrics, Hirosaki University Graduate School of Medicine, Aomori, Japan.
³ Department of Dermatology, Hirosaki University Graduate School of Medicine, Aomori, Japan.
⁴ Department of Dermatology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
⁵ Division of Molecular Medicine, Institute for Genome Research, University of Tokushima, Tokushima, Japan.

PMID: 27333819
DOI: 10.1111/ced.12865

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Child
Dermatitis, Atopic / immunology
Dermatitis, Atopic / pathology
Eosinophilia / blood
Female
Filaggrin Proteins
Humans
Immunoglobulin E / blood*
Intermediate Filament Proteins / genetics
Japan
Job Syndrome / blood
Job Syndrome / drug therapy
Job Syndrome / genetics*
Job Syndrome / pathology
Linezolid / administration & dosage
Linezolid / therapeutic use
Mutation*
Protein Synthesis Inhibitors / therapeutic use
STAT3 Transcription Factor / genetics
Skin Diseases / immunology
Skin Diseases / pathology
Treatment Outcome

Substances

Filaggrin Proteins
Intermediate Filament Proteins
Protein Synthesis Inhibitors
STAT3 Transcription Factor
STAT3 protein, human
Immunoglobulin E
Linezolid